Trails Edge Capital Partners, Lp Portfolio Stock Holdings
According to the SEC 13F filed on August 14, 2026, Trails Edge Capital Partners, Lp disclosed 34 stock positions valued at approximately $629.91M as of quarter-end June 30, 2026. The largest holdings include LB PHARMACEUTICALS INC, NURIX THERAPEUTICS INC, and IMMUNOCORE HLDGS PLC.
- Report Period
- June 30, 2026
- No. of Stocks
- 34
- Portfolio Value
- $629.91M
Holdings by Sector
Trails Edge Capital Partners, Lp Portfolio Holdings in Q2 2026
| Company | Symbol | Sector | Portfolio % | Shares | Change (Shares) | Change % | Value |
|---|---|---|---|---|---|---|---|
| LB PHARMACEUTICALS INC | LBRX | Healthcare | 7.85% | 1,523,022 | +203,660 | +15.44% | $49,429,679 |
| NURIX THERAPEUTICS INC | NRIX | Healthcare | 6.06% | 1,573,220 | -170,000 | -9.75% | $38,166,318 |
| IMMUNOCORE HLDGS PLC | IMCR | Healthcare | 5.36% | 1,063,234 | +380,637 | +55.76% | $33,757,680 |
| FIRST TRACKS BIOTHERAPEUTICS | TRAX | Healthcare | 4.84% | 1,514,000 | +1,514,000 | +100.00% | $30,461,680 |
| 4D MOLECULAR THERAPEUTICS IN | FDMT | Healthcare | 4.70% | 2,227,917 | +925,000 | +70.99% | $29,631,296 |
| BIOMARIN PHARMACEUTICAL INC | BMRN | Healthcare | 4.65% | 512,000 | +512,000 | +100.00% | $29,296,640 |
| DESIGN THERAPEUTICS INC | DSGN | Healthcare | 4.60% | 2,001,282 | +1,149,269 | +134.89% | $28,958,550 |
| XENON PHARMACEUTICALS INC | XENE | Healthcare | 4.22% | 440,000 | - | - | $26,558,400 |
| MIRUM PHARMACEUTICALS INC | MIRM | Healthcare | 4.15% | 223,312 | -110,000 | -33.00% | $26,143,136 |
| INSMED INC | INSM | Healthcare | 3.90% | 230,331 | +230,331 | +100.00% | $24,557,891 |
| CYTOKINETICS INC | CYTK | Healthcare | 3.90% | 288,089 | -11,911 | -3.97% | $24,542,302 |
| SYNDAX PHARMACEUTICALS INC | SNDX | Healthcare | 3.85% | 1,110,000 | +408,179 | +58.16% | $24,264,600 |
| NEUROGENE INC | NGNE | Healthcare | 3.57% | 714,885 | -67,902 | -8.67% | $22,483,133 |
| KAILERA THERAPEUTICS INC | KLRA | Healthcare | 3.44% | 984,786 | +984,786 | +100.00% | $21,694,836 |
| REVOLUTION MEDICINES INC | RVMD | Healthcare | 3.44% | 115,750 | -129,250 | -52.76% | $21,677,660 |
| INHIBIKASE THERAPEUTICS INC | IKT | Healthcare | 2.92% | 9,051,318 | +993,973 | +12.34% | $18,374,176 |
| INCYTE CORP | INCY | Healthcare | 2.79% | 155,000 | +155,000 | +100.00% | $17,570,800 |
| AVALO THERAPEUTICS INC | AVTX | Healthcare | 2.62% | 891,881 | +891,881 | +100.00% | $16,481,961 |
| MOONLAKE IMMUNOTHERAPEUTICS | MLTX | Healthcare | 2.32% | 750,000 | +750,000 | +100.00% | $14,602,500 |
| FAETH THERAPEUTICS INC | FTH | Healthcare | 2.05% | 515,335 | +390,335 | +312.27% | $12,883,375 |
| X4 PHARMACEUTICALS INC | XFOR | Healthcare | 1.91% | 2,571,478 | - | - | $12,008,803 |
| OPUS GENETICS INC | OCUP | Other | 1.79% | 2,743,658 | +2,243,658 | +448.73% | $11,276,434 |
| SOL-GEL TECHNOLOGIES LTD | SLGL | Healthcare | 1.64% | 139,445 | +53,949 | +63.10% | $10,338,452 |
| AURA BIOSCIENCES INC | AURA | Healthcare | 1.63% | 1,443,333 | +1,443,333 | +100.00% | $10,247,665 |
| CENTURY THERAPEUTICS INC | IPSC | Healthcare | 1.61% | 4,134,969 | +1,684,976 | +68.77% | $10,130,674 |
| INVENTIVA SA | IVA | Healthcare | 1.60% | 2,657,997 | - | - | $10,047,228 |
| CAMP4 THERAPEUTICS CORP | CAMP | Healthcare | 1.34% | 1,932,937 | -6,626 | -0.34% | $8,446,935 |
| ALTIMMUNE INC | ALT | Healthcare | 1.28% | 2,660,000 | +2,660,000 | +100.00% | $8,086,400 |
| MINERVA NEUROSCIENCES INC | NERV | Healthcare | 1.25% | 1,419,000 | - | - | $7,875,450 |
| PROMIS NEUROSCIENCES INC | PMN | Healthcare | 1.16% | 557,103 | - | - | $7,331,475 |
Showing 30 of 34 holdings in the latest reporting period.